BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 27, 2009
View Archived Issues
MAP Gets Boost on Positive Phase III Migraine Study
Shares in MAP Pharmaceuticals Inc. spiked 185.7 percent Tuesday on the news that its Phase III migraine study of Levadex hit all four primary objectives. (BioWorld Today)
Read More
Cytokinetics' Cardio Bet Pays Off with Amgen Option Exercise
Read More
Cancer, Depression Have Direct Link in Cytokines, Corticosterone
Read More
United Therapeutics Jumps on Adcirca Approval in PAH
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Financings Roundup
Read More
Appointments And Advancements
Read More